Evidence map›Paper›PMID 36355882›Full record

ArticleTropical medicine and infectious disease2022

Clinical Characteristics Associated with Detected Respiratory Microorganism Employing Multiplex Nested PCR in Patients with Presumptive COVID-19 but Negative Molecular Results in Lima, Peru.

Juan Carlos Gómez de la Torre Pretell, Miguel Hueda-Zavaleta, José Alonso Cáceres-DelAguila, Claudia Barletta-Carrillo, Cesar Copaja-Corzo, Maria Del Pilar Suarez Poccorpachi, María Soledad Vega Delgado, Gloria Maria Magdalena Levano Sanchez, Vicente A Benites-Zapata

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Juan Carlos Gómez de la Torre PretellRoe Clinical Laboratory, Lima 15076, Peru.
Miguel Hueda-ZavaletaFacultad de Ciencias de la Salud, Universidad Privada de Tacna, Tacna 23003, Peru.ORCID 0000-0002-8049-7787
José Alonso Cáceres-DelAguilaRoe Clinical Laboratory, Lima 15076, Peru.ORCID 0000-0001-7897-5033
Claudia Barletta-CarrilloFacultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.ORCID 0000-0001-9982-5368
Cesar Copaja-CorzoFacultad de Ciencias de la Salud, Universidad Privada de Tacna, Tacna 23003, Peru.
Maria Del Pilar Suarez PoccorpachiFacultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.
María Soledad Vega DelgadoFacultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.ORCID 0000-0003-2968-3303
Gloria Maria Magdalena Levano SanchezFacultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.ORCID 0000-0002-5400-6534
Vicente A Benites-ZapataUnidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima 15024, Peru.
National University of San Marcos · PEDaniel Alcides Carrión National University · PEUniversidad Privada de Tacna · PEUniversidad San Ignacio de Loyola · PE

Funding

the Sequence Reference Lab +51017433033Universidad San Ignacio de Loyola +51013171000
6 · The paper itself

Abstract

The COVID-19 pandemic circumstances have varied the pathogens related to acute respiratory infections (ARI), and most specialists have ignored them due to SARS-CoV-2's similar symptomatology. We identify respiratory pathogens with multiplex PCR in samples with presumptive SARS-CoV-2 but negative RT-qPCR results. We performed a retrospective transversal study employing clinical data and nasopharyngeal swab samples from patients with suspected clinical SARS-CoV-2 infection and a negative PCR result in a private laboratory in Lima, Peru. The samples were analyzed using the FilmArray™ respiratory panel. Of 342 samples, we detected at least one pathogen in 50% of the samples. The main ones were rhinovirus (54.38%), influenza A(H3N2) (22.80%), and respiratory syncytial virus (RSV) (14.04%). The clinical characteristics were sore throat (70.18%), cough (58.48%), nasal congestion (56.43%), and fever (40.06%). Only 41.46% and 48.78% of patients with influenza met the definition of influenza-like illness (ILI) by the World Health Organization (WHO) (characterized by cough and fever) and the Centers for Disease Control and Prevention (CDC) (characterized by fever and cough and sore throat), respectively. A higher prevalence of influenza was associated with ILI by WHO (aPR: 2.331) and ILI by CDC (aPR: 1.892), which was not observed with other respiratory viruses. The clinical characteristic associated with the increased prevalence of rhinovirus was nasal congestion (aPR: 1.84). For patients with ARI and negative PCR results, the leading respiratory pathogens detected were rhinovirus, influenza, and RSV. Less than half of patients with influenza presented ILI, although its presence was specific to the disease.

Indexed as

common coldCOVID-19influenzamultiplex polymerase chain reactionpolymerase chain reactionrespiratory tract infectionsrhinovirus

Identifiers

PMID36355882
PMCPMC9692319
OpenAlexW4308127292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.